SCHEMBL2734563

SCHEMBL2734563

Cc1c(C(=O)O)cc(Cl)cc1S(=O)(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43
CYP3A4 P08684 1/20 0.42
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.40
NOTUM Q6P988 1/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
ACLY P53396 5/20 0.39
MYC P01106 1/20 0.39
NR4A1 P22736 1/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11257728 0.82 TPMT (0.41) ALDH1A1HSD17B10CA1CA2CA12
SCHEMBL13537088 0.80 AKR1C4 (0.56) AKR1C4AKR1C3AKR1C2AKR1C1CYP3A4
SCHEMBL11045768 0.80 TRPV4 (0.44) ALDH1A1TP53ACLYCA1CA2
SCHEMBL3531626 0.80 AKR1C2 (0.58) AKR1C4AKR1C3AKR1C2AKR1C1CYP3A4
SCHEMBL15575082 0.79 AKR1C4 (0.43) AKR1C4AKR1C3AKR1C2AKR1C1CYP3A4
SCHEMBL11052920 0.75 CA1 (0.42) CYP3A4ALDH1A1TP53HSD17B10HPGD
SCHEMBL5671303 0.75 AKR1C4 (0.61) AKR1C4AKR1C3AKR1C2AKR1C1CYP3A4
SCHEMBL27705723 0.75 AKR1C4 (0.50) AKR1C4AKR1C3AKR1C2AKR1C1CYP3A4
SCHEMBL3524715 0.74 ALDH1A1 (0.57) AKR1C4AKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL196272 0.74 TRPV4 (0.37) AKR1C4AKR1C3AKR1C2AKR1C1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297103-B1 HYDROXYPHENYLSULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-01-04 EP disclosed